[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical's stock is seeing increased engagement following recent licensing deals, including a significant partnership with Astria Therapeutics for a hyperhidrosis treatment. The company is also collaborating with Alumis and KalVista Pharmaceuticals on new drug commercialization efforts.

### About Kaken Pharmaceutical Co. Ltd.
Kaken Pharmaceutical Co. Ltd. is a Japanese pharmaceutical company.  

### Insights
- Kaken Pharmaceutical Co. Ltd. engagements is up XXXXX% from the previous week.

### Price: $
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/close.tsv)  
The price action is likely influenced by recent licensing agreements and collaborations, particularly the partnership with Astria Therapeutics, which is driving positive sentiment.  

1-Year High: $XXXXX on 2025-03-12  
1-Year Low: $XXXXX on 2025-11-11  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/alt_rank.tsv)  
Kaken Pharmaceutical Co. Ltd. is currently AltRank #1,173 based on combined combined social and market metrics
Daily Average: XXXXX  
1-Year High: XXXXX on 2025-02-27  
1-Year Low: XXX on 2025-11-13  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
1-Year High: XX on 2024-12-19  
1-Year Low: XX on 2025-02-11  
  
  
### Engagements: XX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/interactions.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX +18%  
X Month: XXX -XX%  
X Months: XXXXXX -XX%  
X Year: XXXXXX +2,104%  
1-Year High: XXXXX on 2025-03-25  
1-Year Low: X on 2025-02-08  

Engagements by network (24h):
Reddit: XX
X: X

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: X  
X Week: X no change  
X Month: X -XX%  
X Months: XX -XX%  
X Year: XXX +500%  
1-Year High: XX on 2025-03-25  
1-Year Low: X on 2024-12-19  

Mentions by network (24h):
Reddit: XX
X: X

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning Kaken Pharmaceutical Co. Ltd. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X  
X Week: X no change  
X Month: X -XX%  
X Months: XX -XX%  
X Year: XX +359%  
1-Year High: XX on 2025-03-25  
1-Year Low: X on 2024-12-19  
  
  
### Market Cap: $undefined
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$4521t/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$4521t/time-series/market_cap.tsv)  
Current Value: $undefined  
Daily Average: $XXXXXXXXXXXXXXX  
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-12  
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-25  

### Top Kaken Pharmaceutical Co. Ltd. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Brickell Biotech Announces Initiation of a Phase X Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner Kaken Pharmaceutical in Japan"  
[Reddit Link](https://redd.it/oqg7ub) [@dothebestforyourhope](/creator/reddit/dothebestforyourhope) 2025-06-17T13:25Z X followers, XX engagements


"Alumis lead candidate ESK-001 is a potential best-in-class allosteric TYK2 inhibitor for immune-mediated diseases like plaque psoriasis and SLE. Just last month Kaken Pharmaceutical inked a $40M+ licensing deal for rights in Japanunderscoring confidence in this promising next-generation TYK2 inhibitor. Read more:"  
[X Link](https://x.com/drughunter_com/status/1920138003516690463) [@drughunter_com](/creator/x/drughunter_com) 2025-05-07T15:25Z 10.8K followers, 6464 engagements


"KALV KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan"  
[Reddit Link](https://redd.it/1juab8v) [@Stock_Titan](/creator/reddit/Stock_Titan) 2025-04-08T11:01Z X followers, XX engagements


"$ALMS Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan"  
[X Link](https://x.com/AskEdgarIO/status/1904514065466012131) [@AskEdgarIO](/creator/x/AskEdgarIO) 2025-03-25T12:41Z 2959 followers, XXX engagements